General Research Funding from the CMT Research Foundation supports researchers and clinicians pursuing translational and discovery research to advance treatments for all types of Charcot-Marie-Tooth disease.
CMTRF removed its published award guidance of $100,000–$200,000 per year for one to three years, along with related milestone, follow-on funding and co-funding guidance. It also removed the promise to post application-process updates in October; no replacement timing, award amount or duration was provided.
Research Funding supports researchers, clinicians, and industry worldwide in preclinical research to accelerate progress toward treatments and cures for CMT and related inherited neuropathies.
George and Cleary Simpson Award for Emerging Researchers supports early-career researchers pursuing innovative research within an annual focus area to advance treatments and cures for Charcot-Marie-Tooth disease.
CMTA-STAR Funding from the Charcot-Marie-Tooth Association supports expert-reviewed research advancing therapies for Charcot-Marie-Tooth disease.
The SMA Foundation Research Funding program supports projects that accelerate late-stage translational research or clinical trials for new SMA therapeutics.
PTAC Research Grant supports investigators studying CFTR restoration and gene repair or replacement to inform new therapies for people with cystic fibrosis not served by approved modulators.